Elizabeth Nabel
Cardiovascular Disease · Boston, MANPI 1417260696
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,986,219 of the $2,246,241 with a category attached, or 88.4%. Medtronic accounts for 82.1% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $471,266 and has fallen 81.0% since, to $89,321 in 2025. Among cardiovascular disease clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $6529.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1.8M
- Modernatx, Inc.$403K
What the payments were for
- Consulting fees$1,986,21988%
- Speaking & faculty fees$129,2356%
- Travel & lodging$119,1955%
- Food & beverage$11,5931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 314 | $1,843,063 |
| Modernatx, Inc. | 30 | $403,178 |
How this compares
$2,246,241 in reported general payments places this provider in the 95th percentile of 750 cardiovascular disease providers in Massachusetts.
Other cardiovascular disease in Boston
- Marc SabatineBoston$3.9M
- Kenneth RosenfieldBoston$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
- Ignacio Inglessis-AzuajeBoston$545K
- Jorge PlutzkyBoston$528K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.